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Introduction
Methotrexate (MTX) is a widely used anti-neoplastic 
drug which is considered as first line treatment option 
to patients suffering with cancer (Uzar et al. 2006a). Ad-
ditionally, MTX is a prescribed medicine for other diseases 
like psoriasis, Crohn's disease, autoimmune diseases (e.g., 
rheumatoid arthritis), immunological abnormalities, and 
systemic inflammation (Cetinkaya et al. 2006). It causes 
acute life-threatening side effects in overdose situations 
(Funk et al. 2013; Schwartzberg et al. 2014). However, the 
most severe and widespread problems of toxicity associ-
ated MTX treatment are fever, non-productive cough and 
dyspnoea, pneumonitis and pulmonary fibrosis (Imokawa 
et al. 2000; Jakubovic et al. 2013; Hsu et al. 2003). MTX-
induced toxic effect is dependent on the applied dose 
and found to be occurring up to 60% of disease cases 
(Neuman et al. 1999). MTX in higher doses has restricted 
applications in disease management because of its seri-
ous life-threatening effects on liver (Liang et al. 2004). 
Methotrexate prevents the formation of tetrahydrofolate 
(THF) by dihydrofolate reductase (DHFR) and thus de-
creases reduced folate species and hence, the synthesis of 
purine and pyrimidine precursors, which are necessary 
for the synthesis of nucleic acids (Channa Keshava et al. 
1998; Goodsell et al. 1999). Johovic et al. (2003) reported 
that methotrexate inhibits cytosolic enzymatic activities 
of NADP-dependent dehydrogenases and NADP malic 
enzyme to reduce the availability of NADPH in cells via 
pentose phosphate inhibition pathway. However, the 
exact mechanism underlying the MTX-toxicity remains 
unclear. Previous studies have hypothesized that MTX 
application induces oxidative damage in tissues (Miketova 
et al. 2005; Armagan et al. 2008). Like other anticancer 
synthetic drugs, oxidative stress is reported to have a 
significant role in the pathophysiology of tissue toxicity 
induced by MTX (Atessahin et al. 2005; Fadillioglu et al. 
2003; Uz et al. 2005; Quiles et al. 2002). Earlier studies 
also reported that MTX toxicity results in significant 
reduction in efficacy of the antioxidant enzymes defence 
system and increased sensitivity of cells to ROS (Kolli 
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et al. 2014; Abd et al. 2016). Antioxidants perform an 
essential role in living organisms, and they are capable 
to stop free radical generation. To conquer the adverse 
effect of MTX toxicity, it has been recommended to use 
antioxidants (Block et al. 2008; Miyazono et al. 2004).
Squalene is a marine biomolecule having six isoprene 
units.  It is abundantly available in shark liver oil and other 
sources including olive oil, rice bran oil etc. Squalene is 
an integral part of Mediterranean diet and is incorpo-
rated in traditional medicine as it plays an essential role 
in the treatment of several diseases. Squalene is a highly 
effective natural antioxidant, reported to have ability to 
protect cells from oxidative stress and lipid peroxidation 
(Kabuto et al. 2013). It is key intermediate in cholesterol 
metabolism and exerts lipid lowering and membrane 
stabilizing property (Farvin et al. 2004; Farvin et al. 
2005). Detoxifying activities of squalene were studied 
and was suggested to be having a potential to ameliorate 
the harmful effects of different compounds namely hexa-
chlorobiphenyl, perchlorobenzene, arsenic, theophylline, 
phenobarbital and cyclophosphamide (Richter et al. 1982; 
Kamimura et al. 1992; Fan et al. 1996; Senthilkumar et 
al. 2006a). Relevant studies reported that squalene ex-
hibits anti-neoplastic effect (Smith 2000; Sotiroudis and 
Kyrtopoulos 2008). Though squalene has been identified 
as a natural antioxidant capable of reducing the side 
effect of anti-cancer agents, the ameliorating effects of 
squalene against hepatotoxicity associated with MTX 
administration have not been explored yet. With this 
rationale, this study was designed to demonstrate the 
protective role of squalene to counteract the oxidative 
stress mediated by MTX administration and to serve as 
a free radical inhibitor.
Materials and methods
Drug and chemicals
Methotrexate was procured from Sisco Research Labora-
tory (Mumbai, India). Squalene was obtained as a kind gift 
from Aasha Biochem (Kerala, India).  Remaining reagents/
chemicals used in this study were of standard analytical 
chemicals and were obtained either from Sigma Chemi-
cal (USA) or Sisco Research Laboratory (Mumbai, India).
Animals
Ten-week-old male Wistar strain albino rats, weighing 
100-120 g were selected for the study. All animals were 
housed individually in hygienic and standard environ-
mental conditions of temperature 28 ± 2 ˚C, humidity 
60-70%, 12 h light and 12 h dark cycle in polypropylene 
cages. During the experimental period, the animals were 
fed with a standard diet (M/s Sai Foods, Bangalore, India; 
the diet contained carbohydrate 56.2%, crude protein 
22%, ash 7.5%, total fat 4.2%, crude fibre 3%, glucose 2.5%, 
vitamin 1.8%, sand silica 1.4%, calcium 0.8%, phosphorus 
0.8 %, and provide metabolizable energy of 3600 kcal.) 
and water ad libitum. The experiment was carried out 
according to the guidelines of the Committee for the 
Purpose of Control and Supervision of Experiments on 
Animals (CPCSEA), New Delhi, India and approved by 
the Institutional Animal Ethics Committee of the Central 
Institute of Fisheries Technology, Cochin.
Experimental design
The experimental animals were separated into four 
groups, each group having six animals. Group I (CO-SAL) 
and Group II (CO-MTX) animals were fed on commercial 
feed with added coconut oil at 1.5% level and Group III 
(SQ-SAL) and Group IV (SQ-MTX) animals were fed on 
commercial feed with added squalene at 1.5% level for a 
period of 30 days. Group I and III were intraperitone-
ally (i.p.) injected with 0.5 ml normal saline (0.9%) and 
Group II and IV with 0.5 ml methotrexate (20 mg/kg 
body weight) on 30th day (Saeed et al. 2018). During the 
experimental period body weight of all the animals was 
properly documented. At the end of the experiment, i.e. 
48 h after the MTX/normal saline administration, the 
experimental rats were sacrificed. The sera obtained from 
the collected blood samples were stored properly and used 
for performing various assays including total protein 
(Lowry et al. 1951), total bilirubin (Frederick and Robert 
Lee 1974), AST (Mohur and Cook 1957), ALT (Mohur and 
Cook 1957), LDH (King 1965a) and ALP (King 1965b). 
The results obtained for AST, ALT, LDH were expressed 
in µmol of pyruvate liberated/h/mg protein and ALP in 
µmol of phenol liberated h/mg protein. 
Liver samples were weighed, and a small portion of 
liver tissue was fixed in 10% buffered formalin for histo-
pathological observations. Accurately weighed liver tissue 
samples were homogenized in phosphate buffer at 4 ˚C 
with a tissue homogenizer. The homogenate obtained was 
further centrifuged and the supernatant collected were 
used for conducting different assays like SOD (Misra 
and Fridovich 1972), catalase (Takahara et al. 1960), 
GST (Habig et al. 1974), GSH (Ellman 1959), GPx (Paglia 
and Valentine 1967) and LPO (Ohkawa et al. 1979). The 
obtained results were expressed as SOD: one unit of the 
SOD activity is the amount of protein required to give 
50% inhibition of epinephrine autoxidation. Catalase: 
µmol H2O2 decomposed/min/mg protein; GST: μmol 
1-chloro-2,4-dinitrobenzene conjugate formed/min/
mg protein; GSH: µmol/mg wet tissue; GPx: µmol GSH 





Liver tissues were processed by the standard histopatho-
logical procedure to observe microscopic changes. Briefly, 
liver tissue section was embedded in paraffin and 5 µm 
sections were cut separately. The sections were deparaf-
finized using xylene and ethanol and then washed with 
PBS and permeabilization solution (0.1 M citrate, 0.1% 
Triton X-100). The deparaffinised sections were stained 
with haematoxylin and eosin. The histopathological 
examination of tissues of animals was carried out under 
fluorescence microscope (Olympus BX 60, PA, USA).
Statistical analysis 
The results were stated as mean ± SD for 6 animals. 
The statistical comparisons among studied groups were 
performed with SPSS software program (SPSS.16.0 for 
Windows, SPSS, Chicago, IL) using one-way analysis of 
variance (ANOVA). Duncan’s multiple range comparison 
tests were performed among groups. 
Results and Discussion
Influence of MTX treatment on body weight and relative 
liver weight
In the present study, it was observed that MTX injection 
at single dose results in the decline of the body weight of 
both group II and group IV animals. A signifcant reduc-
tion in the body weight was found in Group II animals 
in comparison with other group animals (Table 1).  These 
variations in body weight might possibly be due to oxi-
dative tissue damage in response to MTX induced toxic 
effect, which was reversed by dietary squalene supple-
mentation. Oxidative stress is one of the key mechanisms 
involved in drugs induced liver toxicity.  A reduced body 
weight in experimental rats after single dose methotrexate 
injection (i.p.) was reported in previous studies (Mogha-
dam et al. 2015). In addition, it was also reported that the 
MTX administration (20 mg/kg, single i.p. injection) in 
experimental rats initiates tissue damage and subsequent 
weight loss in comparison with normal control rats 
(Khafaga and El-Sayed 2018). Squalene pretreatment might 
have inhibited the cell damage due to MTX toxicity and 
maintained the body weight to near normalcy by its tissue 
protecting activity against oxidative stress. The results 
were in line with the previous reports which described 
that squalene exhibited antioxidant defense mechanism 
in tissue and protected the cell membrane from oxidative 
stress (Farvin et al. 2005)
Significant changes observed in the relative liver weight 
of Group II MTX intoxicated rats (Table 1) possibly due 
to the oxidative tissue damage induced by methotrexate. 
Prior treatment with squalene reversed these changes 
in relative liver weight.  In consistence with current 
study,  it has been reported that acute tissue damage and 
alterations in relative liver weights of experimental rats 
receiving a single dose methotrexate (20 mg/kg body 
weight) indicated its toxic effect on tissue (Moghadam et 
al. 2015). Furthermore, other investigators also reported 
that a single intra-peritoneal injection of MTX initiates 
oxidative stress which is evidenced by an elevated level 
of relative liver weight in MTX intoxicated groups com-
pared to control (Asmaa and Yasser 2018; Mukherjee et 
al. 2013). Prior supplementation of squalene in Group IV 
animals perhaps protected the liver cell against oxidative 









Body weight (g) 202.66 ± 2.51c 181.33 ± 1.52a 203.05 ± 0.50c 196.66 ± 2.08b
Relative liver weight (%) 2.15 ± 0.06a 2.94 ± 0.05c 2.12 ± 0.03a 2.32 ± 0.01b
Table 1. Effect of dietary squalene supplementation on body weight and relative liver weight of experiments rats receiving different treatments.









Total protein (mg/100 ml) 7.57 ± 0.07c 5.25 ± 0.05a 7.54 ± 0.10c 6.49 ± 0.06b
Total bilirubin (mg/100 ml) 0.200 ± 0.00a 1.30 ± 0.00c 0.204 ± 0.00a 0.291 ± 0.00b
Table 2. Effect of dietary squalene supplementation on total protein and total bilirubin content of experimental rats receiving different treatments.
Values that have a different superscript letter (a, b, c, d) differ significantly (p < 0.05) among each other.
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in counteracting oxidative stress and cellular damage 
occurred in tissue by its antioxidant and membrane 
stabilizing activity. Earlier it was reported that squalene 
pretreatment in experimental animals effectively restored 
the impaired tissue that was exposed to drug treatment 
(Farvin et al. 2004).
Influence of MTX treatment on total protein and 
total bilirubin level 
Total serum protein levels of MTX administrated groups 
(Group II and IV) were lower in comparison with other 
groups (Table 2). Significant decline was noticed in Group 
II animals when compared with other groups.  Observed 
changes in total protein level depict impaired liver func-
tion probably due to methotrexate administration. These 
observations were in accordance with the previous reports 
which displayed significant depletion of serum protein 
level in MTX intoxicated groups than untreated groups 
(Moghadam et al. 2015). Dietary squalene supplementation 
helps to maintain the serum total protein levels to near 
normal in experimental animals. Normalized protein 
levels in squalene treated group marks its protection of 
liver functions against methotrexate toxicity. The resul-
tant observation is in accordance with the earlier report 
which stated that squalene treatment aids to restore serum 
protein levels to near normal in cyclophosphamide in-
toxicated groups vs untreated group (Senthilkumar et al. 
2006a). The total bilirubin level was found to be increased 
in Group II animals compared to other groups (Table 2). 
Squalene supplementation prevented the increase of total 
bilirubin levels and maintained to normal in group IV 
animals. Abdulzahra and Mohammed (2014) indicated that 
total serum bilirubin level was found to be higher in rats 
treated with MTX group compared with untreated groups. 
Increased total bilirubin level indicates the hepatotoxic-
ity and these results concur with the previous studies 
(Moghadam et al. 2015). Squalene provides protection to 
liver cells and effectively prevents the elevation of serum 
biochemical parameters by its membrane stabilizing 
activity. In the present study, prior supplementation of 
squalene decreased total serum bilirubin levels thereby 
reduced the biochemical alteration induced by metho-
trexate.  The present results were in accordance with the 
previous studies (Senthilkumar et al. 2006a).
Effect of dietary squalene on antioxidant enzyme 
levels of MTX administrated rats
Table 3 shows the protective action of dietary squalene 
supplementations on enzymatic and non-enzymatic anti-
oxidant levels as well as lipid peroxide content in experi-
mental groups. SOD and CAT levels in liver tissue were 
decreased significantly in MTX-administered Group II 
animals as compared to other animals. This may possibly 
be due to the formation of superoxide anions and these 
ions inactivate or reduce the activity of SOD. In fact, SOD 
and CAT levels of liver induced by MTX treatment causes 
marked alteration in the antioxidant status, signifying 
that the cells may possibly be more susceptible to reactive 
oxygen species (Uzar et al. 2006b), leading to failure in the 
efficacy of defence mechanism of antioxidant enzymes 
at cellular level (Miyazono et al. 2004). Squalene is an 
efficient singlet oxygen scavenging molecule like that of 
vitamin E.  In the present study, squalene in Group IV 
inhibited MTX induced inactivation of SOD and CAT 
enzyme activity and retained the cellular antioxidant 
status to near normal. Antioxidant activity of squalene 
is assumed to protect the liver cells from cellular dam-
age induced by MTX and these observations were in line 
with the previous reports (Senthilkumar et al. 2006b).
Methotrexate administration resulted in substantial 
depletion in GST, GSH, GPx levels in group II compared 
with others (group I, III and IV).  MTX intoxication might 
have reduced the cellular defence against toxic metabolites 
in liver of experimental animals. MTX causes significant 
decrease in antioxidant enzymatic level in experimental 
animals and supplementation of certain antioxidants like 
melatonin, taurine is effective in preventing this mecha-









SOD 3.82 ± 0.01d 1.04 ± 0.00a 3.41 ± 0.02c 2.71 ± 0.02b
CAT 10.23 ± 0.31c 2.11 ± 0.02a 11.19 ± 0.26d 9.48 ± 0.41b
GST 7.19 ± 0.02c 3.88 ± 0.02a 7.61 ± 0.06d 6.40 ± 0.04b
GSH 21.48 ± 0.51d 7.99 ± 0.42a 17.13 ± 0.20c 13.96 ± 0.18b
GPx 2.13 ± 0.07c 1.21 ± 0.10a 1.91 ± 0.05b 1.8 ± 0.03b
LPO 1.18 ± 0.03a 2.99 ± 0.01d 1.58 ± 0.01b 1.71 ± 0.02c
Values that have a different superscript letter (a, b, c, d) differ significantly (p < 0.05) among each other.




the observed reduction of antioxidant enzymatic level was 
restored in Group IV animals by squalene supplementa-
tion. Squalene possibly acts as a potent antioxidant as well 
as oxygen scavenging molecule and improves antioxidant 
defence status in liver tissue, which prevents MTX induced 
toxicity. It has been previously reported that squalene 
enhances antioxidant defence mechanism in hepatocytes 
of experimentally induced rats during drug toxicity by 
its antioxidant activity (Rajesh and Lakshmanan 2008).
Lipid peroxidation is an oxidative degradation process 
and is also responsible for nucleotide degradation. In the 
present study, the LPO level of MTX administrated group 
(Group II) was significantly higher than other groups. The 
LPO levels of squalene treated groups (Group I and IV) 
and Group I were in same range. Oxidative stress along 
with free radical generation and intense lipid peroxida-
tion are major problems associated with MTX toxicity 
(Sener et al. 2006).  MTX administration in experimental 
animals might initiate peroxidation of membrane lipids 
and production of free radicals which was reversed by 
dietary squalene supplementation. Squalene significantly 
counteracts the MTX induced lipid peroxidation and oxi-
dative stress which is probably related to its free radical 
scavenging property. Senthilkumar et al. (2006b) stated 
that squalene is effective in attenuating lipid peroxida-
tion reactions in the liver of experimental rats induced 
by anticancer drug and this observation is in line with 
the present study. Previously, it was reported that dietary 
squalene supplementation enhanced the antioxidant de-
fense mechanism in experimental animals by reducing the 
elevated LPO level in cardiac tissue (Farvin et al. 2007). In 
addition, the protective effect of squalene against arsenic 
toxicity is mainly through the eradication of free radicals 
by means of its antioxidant and membrane stabilizing 
properties (Rajesh and Lakshmanan 2008).
Effect of dietary squalene on AST, ALP, ALT and LDH 
levels of MTX administrated rats
The levels of AST, ALP and ALT of MTX treated groups 
(Group II and IV) were increased in comparison with other 
groups, indicating impaired liver functions (Table 4). The 
lactate dehydrogenase (LDH) activity was also increased 
in MTX administrated groups (Group II and IV), whereas 
the prior squalene supplementation in Group IV animals 
showed significantly lower values than Group II animals 
(Table 4). Elevated levels of these marker enzymes in the 
liver tissue of experimental animals could be the indication 
of MTX related hepatotoxicity. MTX administration and 
its effect on liver marker enzymes were also reported by 
other investigators (Karthikeyan 2004; Ramadan et al. 
2008). Moghadam et al. (2015) reported an increased serum 
ALT, AST and LDH activities in liver tissue homogenate 
due to hepatotoxicity induced by MTX.  Methotrexate 
is metabolised in liver and such toxic metabolites pro-
duce oxidative stress subsequently initiating acute liver 
injury in experimental animals. In the present study, 
the treatment with squalene prior to the MTX injection 
resulted in the reduction of these parameters to control 
levels. Squalene by its free radical scavenging property 
possibly trapped the toxic metabolites produced in liver 
during the activation of this anticancer drug. Similarly, 
dietary squalene supplementation could be effective in 
preventing experimentally induced oxidative damage in 
hepatocytes and subsequent liver toxicity by its potential 
antioxidant and membrane stabilising activity. Earlier it 
was reported that dietary squalene supplementation ef-
fectively prevented the elevation of serum AST, ALT, ALP 
and LDH levels in kidney and liver tissue of experimental 
animals induced by cyclophosphamide (anticancer drug) 
by means of its antioxidant and free radical scavenging 
activity (Senthilkumar et al. 2006a). In addition, squalene 
supplementation decreased serum diagnostic marker 
enzymes’ level and exerts protection on cardiac tissue 
of experimental animals by its membrane stabilising 
property (Farvin et al. 2004).
Histopathological examination 
The examination of liver sections showed normal ar-
chitecture of central vein, blood sinusoidal, portal triad 









AST 129.28 ± 0.44a 274.81 ± 0.23c 130.28 ± 0.28a 179.81 ± 0.33b
ALT 136.48 ± 0.52a 255.38 ± 0.54d 147.47 ± 0.71b 164.95 ± 0.16c
LDH 199.38 ± 0.58a 377.67 ± 0.66c 195.77 ± 0.40a 231.10 ± 0.20b
ALP 126.39 ± 0.60b 197.19 ± 0.66d 123.36 ± 0.25a 157.26 ± 0.53c
Values that have a different superscript letter (a, b, c, d) differ significantly (p < 0.05) among each other.
Table 4.  Effects of dietary squalene supplementation on serum biochemical parameters of experimental rats receiving different treatments.
Effect of squalene for counteracting oxidative damage
203
2). But MTX administrated groups (Group II and IV) 
displayed irregular central vein with massive inflam-
matory reactions, degenerative changes in portal triad, 
swelling of nucleus in hepatocytes and blood sinusoids 
were compressed. Dietary squalene supplementation to 
experimental animals considerably improved cell struc-
ture with regenerative changes in portal triad and cell 
sinusoidal with separated blood sinusoids. Histological 
studies also confirmed the hepatoprotective effect of 
squalene on MTX induced toxicity.
The histopathological observations in this study, con-
firmed that squalene inverted the increase of free radical 
generation. Thus, it is likely that the hepatoprotective 
mechanism of squalene could be due to its antioxidant 
activity and its ability to scavenge a wide range of free 
radicals. Earlier it was reported that squalene inhibit 
generation of free radicals and lipid hydroperoxides 
(Kabuto et al. 2013).
Conclusion
In conclusion, dietary supplementation of squalene can 
attenuate methotrexate-induced liver dysfunctions. Squa-
lene could reduce the free radical formation during MTX 
induced toxicity. Therefore, squalene might serve as a 
potential as well as effective dietary supplement in reduc-
ing the complications of MTX induced liver injury and 
related hepatotoxicity during cancer treatment. Hence, 
the results of present study suggest that the oral in-take 
of squalene has prominent attenuating effect against 
oxidative stress and subsequent liver injury induced by 
MTX and can serve as therapeutic alternative.
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